• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti-Aging Studies
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for novel

novel

Will new Alzheimer’s drug deliver more than profits?

June 20, 2021

A new Alzheimer’s drug. That has always been the dream.

Filed Under: On Your Health Tagged With: adam, Alzheimer, alzheimer's disease, clinical, cohen, column, drug, neurodegeneration, new, news, newsok, novel, OKC, Oklahoma Medical Research Foundation, OMRF, president, trial

Researchers from OU, OU Health and OMRF detect evidence of coronavirus variants in Oklahoma wastewater

February 26, 2021

Oklahoma City-County Health Department will use wastewater data in response planning.

Filed Under: COVID-19 News, News Tagged With: anadarko, coronavirus, county, covid, covid-19, department, Graham Wiley, health, management, method, midwest city, new, news, Norman, novel, occhd, OKC, Oklahoma City, oklahoma county health department, Oklahoma Medical Research Foundation, OMRF, ou, ou health, Pandemic, response, strategy, testing, Tulsa, variant, virus, waste, wastewater, water

Scientists break new ground with old technique to find answers to arthritis

June 12, 2019

OMRF scientists Tim Griffin and Albert Batushansky are pushing the bounds of a decades-old scientific method to study the origins of osteoarthritis.

Filed Under: News Tagged With: albert batushansky, arthritis, cartilage, drug, gc-ms, Griffin, metabolism, newsok, novel, oa, OKC, Oklahoma City, Oklahoma Medical Research Foundation, oklahoman, OMRF, osteoarthritis, scientist-news, solutions, therapy, Tim Griffin, Timothy, timothy griffin, treatment

OMRF receives $5.9 million grant to study bleeding

April 11, 2019

OMRF researcher Courtney Griffin received a seven-year grant to pursue novel research into blood vessel function and factors that lead to uncontrolled bleeding.

Filed Under: News Tagged With: aneurysms, bleeding, blood, courtney griffin, federal, funding, grant, Griffin, national heart lung and blood institute, newsok, NHLBI, NIH, novel, OKC, Oklahoma Medical Research Foundation, OMRF, program, r35, stephen prescott, uncontrolled

OMRF enters into a license agreement with Shanghai RAAS Blood Products

February 13, 2018

OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.

Filed Under: News, Technology Ventures News Tagged With: Activated Protein C, agreement, americans, antibody, apc, approval, blood, blood clots, breakthrough, CDC, Charles, charles esmon, China, chuck esmon, deal, death, disorder, drug, Esmon, forbes, hemophilia, injuries, innovation, license, Manu Nair, new, news, newsok, novel, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, products, research, rights, scientist-news, sepsis, shanghai raas, technology, trauma, traumatic bleeding, treatment

OMRF collaborates with GSK to develop novel treatments for severe inflammatory diseases

July 24, 2017

This collaboration is part of GSK’s “Discovery Partnerships with Academia” (DPAc) efforts.

Filed Under: News, Technology Ventures News Tagged With: acute pancreatitis, agreement, blood, business, Charles, charles esmon, chuck esmon, collaboration, company, death, discovery partnerships with academia, dpas, drug, Esmon, Florea, Florea Lupu, gsk, healthcare, histones, lung injury, Lupu, newsok, nonprofit, novel, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, organ damage, padmaja mehta-D-souza, partner, research, scientist-news, scientists, therapy, toxic, trauma

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayGive Smart OKCTop Workplace